Currently, the risk of BCR in patients with primary PCa after RP is mainly predicted based on clinical factors such as PSA levels, Gleason score, surgical margins, and lymph node metastasis [62]. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.